EcoSynthetix Q3 2026 results
- Net sales were $3.6 million in Q3 2026, down 38% year‑over‑year, driven by a 41% decline in volumes.
- Adjusted EBITDA was $39,400 for Q3 2026 and Adjusted EBITDA loss was $0.5 million YTD 2026.
- Cash on hand and term deposits totaled $29.4 million as at September 30, 2026, and the company repurchased 23,000 shares in Q3.
- Won a new commercial account with a global top‑five tissue producer and expanded South American distribution for pulp and paper.
Quarter overview
Net sales were $3.6 million for Q3 2026 and $12.0 million YTD, versus $5.8 million and $14.9 million in the comparable 2025 periods. The quarterly sales decline of $2.2 million (38%) was primarily due to a 41% drop in volumes across key end markets.
Operational developments
The company secured a new commercial account with a global top‑five tissue producer running SurfLock™ at one facility and extending trials, and expanded distribution partnerships in South America focused on pulp and paper conversions.
Financial performance
Gross profit was $1.1 million in Q3 (30.7% of sales) and $3.3 million YTD. Adjusted EBITDA was $39,400 in Q3 and a loss of $0.5 million YTD. Net loss was $0.3 million for Q3 and $1.3 million YTD, with lower interest income contributing to the YTD increase.
Liquidity and capital actions
Cash and term deposits were $29.4 million at September 30, 2026. Under the NCIB, the company purchased and cancelled 23,000 shares in Q3 and 329,595 shares YTD for aggregate consideration of $0.03 million and $0.8 million, respectively.
Management view
Management says technical validation and commercial relationships are in place but adoption is slower than expected; priority is driving higher usage among existing and new customers to restore growth.
Source: EcoSynthetix